Academic Journal
Key Performance Indicators for Clinical Pharmacy Practice and Administration in Inpatient/Acute Care Settings: An Opinion of the Clinical Administration Practice and Research Network of the American College of Clinical Pharmacy.
| Τίτλος: | Key Performance Indicators for Clinical Pharmacy Practice and Administration in Inpatient/Acute Care Settings: An Opinion of the Clinical Administration Practice and Research Network of the American College of Clinical Pharmacy. |
|---|---|
| Συγγραφείς: | Mercado A; Rady Children's Health, Orange, California, USA., Noble JM; Mayo Clinic Health System - MN, Rochester, Minnesota, USA., Irwin AN; Oregon State University, College of Pharmacy, Corvalis, Oregon, USA., Badowski ME; University of Illinois Chicago, Retzky College of Pharmacy, Chicago, Illinois, USA., Bangalore N; Children's Wisconsin, Milwaukee, Wisconsin, USA., Caliendo G; The Mount Sinai Hospital, New York, New York, USA., Chan DCM; University of Illinois Chicago, Retzky College of Pharmacy, Chicago, Illinois, USA., Dumont ZJ; Saskatchewan Health Authority - Pasqua Hospital, Regina, Saskatchewan, Canada., Groth CM; University of Rochester Medical Center, Rochester, New York, USA., Humaideh MA; SEHA Sheikh Khalifa Medical City, Abu Dhabi, UAE., Nguyen T; Massachusetts General Hospital, Boston, Massachusetts, USA., Salvatus M; West Coast University, School of Pharmacy, Sunland, California, USA., Sullivan JB; Jersey Shore University Medical Center, Neptune City, New Jersey, USA., Thambi M; University of Illinois Chicago, Retzky College of Pharmacy, Chicago, Illinois, USA., Welch RW; Baptist Memorial Hospital - Golden Triangle, Columbus, Mississippi, USA., Parrish RH 2nd; Alice L. Walton School of Medicine, Bentonville, Arkansas, USA. |
| Πηγή: | Journal of the American College of Clinical Pharmacy : JACCP [J Am Coll Clin Pharm] 2026 Aug; Vol. 9 (8), pp. e70252. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Wiley Country of Publication: United States NLM ID: 101723133 Publication Model: Print Cited Medium: Internet ISSN: 2574-9870 (Electronic) Linking ISSN: 25749870 NLM ISO Abbreviation: J Am Coll Clin Pharm Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [Hoboken, NJ] : Wiley, [2018]- |
| Ιατρικοί όροι (MeSH): | Pharmacy Service, Hospital*/standards , Pharmacy Service, Hospital*/organization & administration , Quality Indicators, Health Care*/standards , Societies, Pharmaceutical*/standards , Pharmacists*/standards , Pharmacists*/organization & administration, Humans ; United States ; Inpatients ; Professional Role ; Delphi Technique |
| Περίληψη: | Key performance indicators (KPIs) are quantifiable measures that describe critical success factors of an organization. Their vital role in ensuring the delivery of quality health care services necessitates the development of KPIs relevant to inpatient clinical pharmacy practice. This opinion paper from the American College of Clinical Pharmacy (ACCP) Clinical Administration Practice and Research Network (CADM PRN) describes the rationale, methodology, and outcomes of a consensus process to identify a focused set of inpatient/acute care clinical pharmacy KPIs. Leveraging a modified Delphi approach, the CADM PRN convened an Expert Panel of clinical pharmacy leader members to build a consensus-driven set of KPIs reflecting clinical, operational, patient-centered, and financial contributions of clinical pharmacists in the inpatient/acute care setting. From a previous ACCP White Paper, a total of 15 KPIs were identified across four domains: (1) clinical practice and patient safety, (2) clinical outcomes and readmissions, (3) medication education and patient engagement, and (4) financial and operational value. The CADM PRN posits that the establishment and implementation of standardized KPIs are essential for measuring and demonstrating the value of clinical pharmacy services in modern health care, offers pragmatic, consensus-based KPIs for evaluating clinical pharmacy services supporting resource justification, and advancing the visibility and impact of pharmacists in acute care practice. As hospitals shift toward value-based care, robust KPI frameworks will be critical for optimizing patient outcomes, supporting financial sustainability, and justifying appropriate staffing. Future efforts should focus on pilot testing, addressing implementation barriers, and achieving broader acceptance for KPIs across the profession. (© 2026 ACCP Foundation, Ltd.) |
| Σχόλια: | Erratum in: J Am Coll Clin Pharm. 2026 Aug;9(8):e70268. doi: 10.1002/jac5.70268.. (PMID: 42503562) |
| References: | A. Talebpour, H. Sadeghi‐Bazargani, A. Janati, F. Pashazadeh, and M. Gholizadeh, “Crucial Key Performance Indicators for Hospital Evaluation: A Scoping Review,” Journal of Education Health Promotion 14 (2025): 195, https://doi.org/10.4103/jehp.jehp_2102_23. S. N. Kucukarslan, K. Corpus, N. Mehta, et al., “Evaluation of a Dedicated Pharmacist Staffing Model in the Medical Intensive Care Unit,” Hospital Pharmacy 48, no. 11 (2013): 922–930, https://doi.org/10.1310/hpj4811‐922. S. L. Si, X. Y. You, H. C. Liu, and J. Huang, “Identifying Key Performance Indicators for Holistic Hospital Management With a Modified DEMATEL Approach,” International Journal of Environmental Research and Public Health 14, no. 8 (2017): 934, https://doi.org/10.3390/ijerph14080934. O. Fernandes, S. K. Gorman, R. S. Slavik, et al., “Development of Clinical Pharmacy Key Performance Indicators for Hospital Pharmacists Using a Modified Delphi Approach,” Annals of Pharmacotherapy 49, no. 6 (2015): 656–669, https://doi.org/10.1177/1060028015577445. E. Lo, D. Rainkie, W. M. Semchuk, et al., “Measurement of Clinical Pharmacy Key Performance Indicators to Focus and Improve Your Hospital Pharmacy Practice,” Canadian Journal of Hospital Pharmacy 69, no. 2 (2016): 149–155, https://doi.org/10.4212/cjhp.v69i2.1543. M. Lee, M. E. Badowski, N. M. Acquisto, et al., “ACCP Template for Evaluating a Clinical Pharmacist,” Pharmacotherapy 37, no. 5 (2017): e21–e29, https://doi.org/10.1002/phar.1927. J. J. Saseen, T. L. Ripley, D. Bondi, et al., “ACCP Clinical Pharmacist Competencies,” Pharmacotherapy 37, no. 5 (2017): 630–636, https://doi.org/10.1002/phar.1923. L. Magedanz, H. L. Silva, D. Galato, and F. Fernandez‐Llimos, “Clinical Pharmacy Key Performance Indicators for Hospital Inpatient Setting: A Systematic Review,” International Journal of Clinical Pharmacy 46, no. 3 (2024): 602–613, https://doi.org/10.1007/s11096‐024‐01717‐x. M. S. Heavner, C. Rose, M. Dormer, J. A. Morgan, and S. T. Haines, “Characterization of Faculty Practice Evaluation Processes Within US Schools of Pharmacy,” Journal of the American College of Clinical Pharmacy 8 (2025): 1–7, https://doi.org/10.1002/jac5.700. R. J. Cipolle, L. M. Strand, and P. C. Morley, Pharmaceutical Care Practice: The Patient‐Centered Approach to Medication Management, 3rd ed. (McGraw‐Hill Education, 2012). A. S. Al‐Jazairi and A. O. Alnakhli, “Quantifying Clinical Pharmacist Activities in a Tertiary Care Hospital Using Key Performance Indicators,” Hospital Pharmacy 56, no. 4 (2021): 321–327, https://doi.org/10.1177/0018578719897074. L. V. Minard, H. Deal, M. E. Harrison, K. Toombs, H. Neville, and A. Meade, “Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators,” PLoS One 11, no. 4 (2016): e0152903, https://doi.org/10.1371/journal.pone.0152903. F. Boucher, B. Lemire, S. Schryve, and L. Vaillant, “Selecting Performance Indicators for Hospital Pharmacy Practice: A Canadian Initiative,” Journal of Pharmacy Practice and Research 53 (2023): 282–290, https://doi.org/10.1002/jppr.1880. J. F. F. de Souza, B. D. Fernandes, I. Rotta, R. Pontarolo, and C. J. Correr, “Key Performance Indicators for Pharmaceutical Services: A Systematic Review,” Exploratory Research in Clinical and Social Pharmacy 14 (2024): 100441, https://doi.org/10.1016/j.rcsop.2024.100441. A. R. Cossart, M. L. Canning, F. R. Yong, and C. R. Freeman, “Benchmarking Hospital Clinical Pharmacy Practice Using Standardized Key Performance Indicators (KPIs),” Journal of Pharmaceutical Policy and Practice 17 (2024): 2431181, https://doi.org/10.1080/20523211.2024.2431181. N. M. Acquisto, C. J. Beavers, S. Bolesta, et al., “Development and Application of Quality Measures of Clinical Pharmacist Services Provided in Inpatient/Acute Care Settings,” Journal of the American College of Clinical Pharmacy 4, no. 12 (2021): 1601–1617, https://doi.org/10.1002/jac5.1559. D. P. Nau, “Measuring Pharmacy Quality,” Journal of the American Pharmaceutical Association 49, no. 2 (2009): 154–163, https://doi.org/10.1331/JAPhA.2009.09019. P. J. Kaboli, A. B. Hoth, B. J. McClimon, and J. L. Schnipper, “Clinical Pharmacists and Inpatient Medical Care: A Systematic Review,” Archives of Internal Medicine 166, no. 9 (2006): 955–964, https://doi.org/10.1001/archinte.166.9.955. M. A. Heenan, G. E. Randall, and J. M. Evans, “Selecting Performance Indicators and Targets in Health Care: An International Scoping Review and Standardized Process Framework,” Risk Management and Healthcare Policy 15 (2022): 747–764, https://doi.org/10.2147/RMHP.S357561. American Hospital Association Trustee Services, “Dashboards and Balanced Scorecards: Best Board Practices Checklist,” accessed 2025, https://trustees.aha.org/dashboards‐and‐balanced‐scorecards. A. Jorm, “Using the Delphi Method to Establish Expert Consensus,” in Advancing Methods for Interdisciplinarity in Social Sciences (Palgrave Macmillan, 2025), https://doi.org/10.1007/978‐981‐96‐8357‐4. M. Jaam, A. Awaisu, A. El‐Awaisi, et al., “Use of the Delphi Technique in Pharmacy Practice Research,” Research in Social and Administrative Pharmacy 18, no. 1 (2022): 2237–2248, https://doi.org/10.1016/j.sapharm.2021.06.028. A. H. Jakobsen, N. Sato, T. F. Chen, and I. Krass, “Development of Quality Indicators for a Community Pharmacy Setting,” International Journal of Pharmacy Practice 33, no. 4 (2025): 386–392, https://doi.org/10.1093/ijpp/riaf030. T. McFarlane, R. Sothilingam, O. Fernandes, et al., “Development of Ambulatory Oncology Clinical Pharmacy Key Performance Indicators Using a Modified Delphi Consensus Approach,” JCO Oncology Practice 22, no. 6 (2025): OP2500353, https://doi.org/10.1200/OP‐25‐00353. L. Wu, Z. Lv, M. Chen, et al., “Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (Version 2),” Frontiers in Public Health 12 (2025): 1472355, https://doi.org/10.3389/fpubh.2024.1472355. Pharmacy Quality Alliance, “Medication Therapy Problem (MTP) Categories Framework,” PQA, 2023, https://www.pqaalliance.org/mtp‐categories‐framework. L. T. Armistead, A. D. Pyan, B. Williams, et al., “Medication Therapy Problem Documentation and Reporting: A Review of the Literature and Recommendations,” Journal of the American College of Clinical Pharmacy 4, no. 10 (2021): 1337–1347, https://doi.org/10.1002/jac5.1514. L. T. Kohn, J. M. Corrigan, and M. S. Donaldson, eds., To Err Is Human: Building a Safer Health System (National Academies Press, 2000). Q. N. Bach, S. K. Peasah, and E. Barber, “Review of the Role of the Pharmacist in Reducing Hospital Readmissions,” Journal of Pharmacy Practice 32, no. 6 (2019): 617–624, https://doi.org/10.1177/0897190018765500. S. R. Kahn, W. Lim, A. S. Dunn, et al., “Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines,” Chest 141, no. 2 Suppl (2012): e195S–e226S, https://doi.org/10.1378/chest.11‐2296. C. A. Bond and C. L. Raehl, “Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates,” Pharmacotherapy 27, no. 4 (2007): 481–493, https://doi.org/10.1592/phco.27.4.481. A. Muir, M. C. Rodriguez, S. C. Kang, et al., “Provision of Medication Supply at Hospital Discharge: A Rapid Scoping Review of the “Meds‐To‐Beds” Care Model,” American Journal of Health‐System Pharmacy 83, no. 3 (2026): e105–e114, https://doi.org/10.1093/ajhp/zxaf151. American Society of Health‐System Pharmacists, “ASHP Statement on the Pharmacist's Role in Substance Use Disorder Prevention, Treatment, and Recovery,” 2025, https://www.ashp.org/‐/media/assets/policy‐guidelines/docs/Statements‐Pre‐Publication/pharmacists‐role‐SUD‐prevention‐and‐recovery.pdf. M. B. Ayalew, H. G. Tegegn, and O. Abdela, “Drug Related Hospital Readmissions: A Systematic Review of the Recent Literatures,” Bulletin of Emergency and Trauma 7, no. 4 (2019): 339–346, https://doi.org/10.29252/beat‐070401. American Society of Health‐System Pharmacists, “ASHP Statement on the Pharmacist's Role in Medication Reconciliation,” American Journal of Health‐System Pharmacy 70 (2013): 453–456, https://doi.org/10.2146/sp120009. F. G. Yumrucu, E. Kara, L. Yumrukaya, et al., “Clinical Pharmacist‐Led Implementation of an Intravenous‐To‐Oral Antimicrobial Switch Protocol: A Prospective Quasi‐Experimental Study,” Journal of Infection and Chemotherapy 32, no. 3 (2026): 102925, https://doi.org/10.1016/j.jiac.2026.102925. S. P. Bell, J. L. Schnipper, K. Goggins, et al., “Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial,” Journal of General Internal Medicine 31, no. 5 (2016): 470–477, https://doi.org/10.1007/s11606‐016‐3596‐3. K. L. March, M. J. Peters, C. K. Finch, et al., “Pharmacist Transition‐of‐Care Services Improve Patient Satisfaction and Decrease Hospital Readmissions,” Journal of Pharmacy Practice 35, no. 1 (2022): 86–93, https://doi.org/10.1177/0897190020958264. Centers for Medicare & Medicaid Services, “HCAHPS: Patients' Perspectives of Care Survey,” 2025, https://www.cms.gov/medicare/quality/initiatives/hospital‐quality‐initiative/hcahps‐patients‐perspectives‐care‐survey. American Society of Health‐System Pharmacists, “ASHP Value‐Based Care Implementation Resource Guide,” 2025, https://www.ashp.org/‐/media/assets/pharmacy‐practice/resource‐centers/ambulatory‐care/docs/ASHP‐Value‐Based‐Care‐Implementation‐Resource‐Guide.pdf. Centers for Medicare & Medicaid Services, “Fact Sheet: FY 2025 Hospital Inpatient Prospective Payment System (IPPS) and Long‐Term Care Hospital Prospective Payment System (LTCH PPS) Final Rule—CMS‐1808‐F,” 2025, https://www.cms.gov/newsroom/fact‐sheets/fy‐2025‐hospital‐inpatient‐prospective‐payment‐system‐ipps‐and‐long‐term‐care‐hospital‐prospective‐0. P. J. Schneider, M. G. Gift, Y. P. Lee, E. A. Rothermich, and B. E. Sill, “Cost of Medication‐Related Problems at a University Hospital,” American Journal of Health‐System Pharmacy 52, no. 21 (1995): 2415–2418, https://doi.org/10.1093/ajhp/52.21.2415. R. A. Mohammad, K. D. Betthauser, R. B. Korona, et al., “Clinical Pharmacist Services Within Intensive Care Unit Recovery Clinics: An Opinion of the Critical Care Practice and Research Network of the American College of Clinical Pharmacy,” Journal of the American College of Clinical Pharmacy 3 (2020): 1369–1379, https://doi.org/10.1002/jac5.1311. M. Jermini, C. Fonzo‐Christe, K. Blondon, et al., “Financial Impact of Medication Reviews by Clinical Pharmacists to Reduce in‐Hospital Adverse Drug Events: A Return‐On‐Investment Analysis,” International Journal of Clinical Pharmacy 46, no. 2 (2024): 496–505, https://doi.org/10.1007/s11096‐023‐01683‐w. B. Wasef, K. Daley, A. Nam, F. Bader, and A. Sauer, “Bridging Gaps in GDMT: Pharmacist‐Medicine Team Synergy for Improved Care,” JACC: Case Reports 30, no. 18 (2025): 103894, https://doi.org/10.1016/j.jaccas.2025.103894. Royal Pharmaceutical Society, Professional Standards for Hospital Pharmacy Services: Optimising Patient Outcomes From Medicines (Royal Pharmaceutical Society, 2014). Canadian cpKPI Collaborative/Coopérative Canadienne d'ICPpc, “Canadian Clinical Pharmacy Key Performance Indicator (cpKPI) Collaborative,” 2026, https://www.cpkpi.ca/. A. Carroccia, O. A. Fernandes, K. Toombs, et al., “What Clinical Pharmacy Key Performance Indicator Processes of Care Were Patients Receiving Across Canada in 2018? A National Patient Registry and Pooled Analysis,” Canadian Journal of Hospital Pharmacy 78, no. 4 (2025): e3819, https://doi.org/10.4212/cjhp.3819. J. B. Gartner and C. Lemaire, “Dimensions of Performance and Related Key Performance Indicators Addressed in Healthcare Organisations: A Literature Review,” International Journal of Health Planning and Management 37, no. 4 (2022): 1941–1952, https://doi.org/10.1002/hpm.3452. J. A. Szwak, R. A. Assadi, J. Gonzalez, et al., “Nationwide Evaluation of the Clinical Impact of Acute Care Adult Medicine Pharmacists,” Journal of the American College of Clinical Pharmacy 7, no. 4 (2024): 342–348, https://doi.org/10.1002/jac5.1916. |
| Contributed Indexing: | Keywords: benchmarking; hospitals; indicator; pharmacists; pharmacy service |
| Entry Date(s): | Date Created: 20260711 Date Completed: 20260711 Latest Revision: 20260726 |
| Update Code: | 20260727 |
| DOI: | 10.1002/jac5.70252 |
| PMID: | 42432869 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!